Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioVacSafe: Quadrivalent Influenza Vaccine Biomarkers
NCT03160118Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2017
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Influsplit in influenza, sponsored by Ghent University Hospital. Started Mar 2017; status: completed.
02
Drugs
Influsplit
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03160118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160118.